ACAN (ACAN) Stock Price & Analysis
ACAN (ACAN) rose 0.00% to USD 0 as of June 10, 2026 at 02:25 UTC, according to Nexqual real-time market data.
ACAN last closed at USD 0; the session ranged USD 0–0 on volume of 16,000 shares. Market capitalization is $2,439, with a 52-week range of USD 0–0.12 (PNK). Source: Nexqual, June 10, 2026 at 02:25 UTC.
Key Statistics (as of June 10, 2026 at 02:25 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.12 |
| Volume | 16,000 shares |
| Market Cap | $2,439 |
| Exchange | PNK |
Technical Analysis (ACAN)
Nexqual's technical model rates ACAN "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 52.73 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (ACAN)
Wall Street analysts rate ACAN "None", per Nexqual as of June 10, 2026 at 02:25 UTC.
| Consensus Rating | None |
|---|
Earnings (ACAN)
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financials & Fundamentals (ACAN)
| Total Revenue | $799,181 |
|---|---|
| Gross Margin | +99.80% |
| Operating Margin | -144.23% |
| Profit Margin | -297.94% |
| ROE | -54.80% |
| Debt / Equity | 215.22 |
| Current Ratio | 0.09 |
| Total Cash | $131,156 |
| Total Debt | $6.79M |
| Free Cash Flow | $-371,983 |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financial Health Score (ACAN)
Nexqual rates ACAN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $131K cash vs $7M debt |
| Cash Flow | Weak — FCF negative: -$372K, burning cash |
| Efficiency | Critical — ROE -55%, ROA -5.7% |
Ownership (ACAN)
| Insider Ownership | +43.02% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 24.39M |
| Float | 13.90M |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Leadership (ACAN)
ACAN is led by Timothy Ryan Keogh (age 45), CEO, President & Director, per Nexqual as of June 10, 2026 at 02:25 UTC.
| CEO, President & Director | Timothy Ryan Keogh (age 45) |
|---|---|
| Founder, Chief Financial & Accounting Officer and Director | Benjamin J. Barton (age 60) |
Major Backers & Investors (ACAN)
Notable institutional backers of ACAN include MAI Capital Management, according to Nexqual as of June 10, 2026 at 02:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| MAI Capital Management | 0.46% |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMMJ | American Cannabis Company, Inc. | USD 0 | ▲ 0% |
| KAYS | Kaya Holdings, Inc. | USD 0.02 | ▲ 0% |
| INQD | Indoor Harvest Corp. | USD 0 | ▲ 0% |
| AXIM | Axim Biotechnologies, Inc. | USD 0 | ▼ 20% |
| AERO | Grupo Aeromexico, S.A.B. de C.V | USD 16.68 | ▲ 3.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:25 UTC. This page is informational and not investment advice.